Actinium Pharmaceuticals Inc. (Delaware) (ATNM)
ATNM trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9995
-5.71% on the day
Market cap
$31.4M
Nano cap
Revenue · 2025
$90K
Prior year not contiguous
Net income · 2025
-$33.9M
-37652.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ATNM on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001388320 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $90K |
| Net income | -$33.9M |
| Operating income | -$36.2M |
| Net margin | -37652.2% |
| Operating margin | -40274.4% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $48.0M |
| Total assets | $51.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 349.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | S-3 | 2023-08-11 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-30 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-07 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-14 |
| Latest proxy PROXY STATEMENT | DEF 14A | 2025-11-05 |
Source: SEC EDGAR submissions feed, 506 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RMTI | Rockwell Medical Inc. | $7.85 | +3.70% | $31.6M |
| BCTX | BriaCell Therapeutics Corp. Common Shares | $3.71 | -4.13% | $32.3M |
| CPHI | China Pharma Holdings Inc. | $0.7514 | -13.53% | $32.3M |
| GRDX | GridAI Technologies Corp. | $4.55 | -2.36% | $32.4M |
| JAGX | Jaguar Health Inc. | $4.16 | -10.35% | $32.5M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier